Super-enhancer-hijacking RBBP7 potentiates metastasis and stemness of breast cancer via recruiting NuRD complex subunit LSD1

  • 0Department of Thyroid and Breast Surgery, Southwest Hospital, Army Medical University, Chongqing, China.

|

|

Summary

This summary is machine-generated.

RBBP7 promotes breast cancer stemness and metastasis by interacting with LSD1. Targeting the SE-RBBP7-LSD1 axis with ORY-1001 offers a potential therapeutic strategy for breast cancer.

Area Of Science

  • Oncology
  • Epigenetics
  • Molecular Biology

Background

  • Aberrant epigenetic and transcriptional events drive cancer progression.
  • RBBP7's role in breast cancer (BCa) stemness and metastasis requires investigation.

Purpose Of The Study

  • To uncover the epigenetic roles of RBBP7 in breast cancer stemness and metastasis.
  • To identify RBBP7 as a potential therapeutic target for breast cancer.

Main Methods

  • Bioinformatic analysis, CCK8, colony formation, and Transwell assays assessed RBBP7's clinical significance and oncogenic functions.
  • ChIP-qPCR, dual-luciferase reporter, tumor sphere formation, and tail vein injection assays investigated epigenetic mechanisms and metastatic efficiency.
  • Patient-derived organoid (PDO) and patient-derived xenograft (PDX) models evaluated ORY-1001 efficacy.

Main Results

  • RBBP7 is upregulated in BCa, correlating with poor prognosis and enhanced proliferation/metastasis.
  • A novel RBBP7-super-enhancer (SE) was identified, crucial for maintaining RBBP7 levels and BCa malignancy.
  • RBBP7 promotes stemness by recruiting LSD1 to demethylate H3K9me3 at stemness gene promoters (SOX9/SOX2/OCT4/CCND1), enhancing self-renewal and metastasis.

Conclusions

  • The SE-RBBP7-LSD1 axis is a key driver of breast cancer stemness and metastasis.
  • Pharmacological inhibition of LSD1 by ORY-1001 effectively suppressed RBBP7-high BCa growth and stemness.
  • The SE-RBBP7-LSD1 axis represents a promising therapeutic target for breast cancer treatment.

Related Concept Videos

Abnormal Proliferation 02:23

4.4K

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

The <em>Ras</em> Gene 02:38

6.1K

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...

Metastasis 02:30

5.5K

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

mTOR Signaling and Cancer Progression 03:03

3.7K

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Interactions Between Signaling Pathways 01:19

6.2K

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

Induced Pluripotent Stem Cells 01:06

3.9K

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...